Structure of PFK158
CAS No.: 1462249-75-7
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
PFK-158 is a potent and selective inhibitor of PFKFB3 that is currently being investigated in a phase I study in patients with advanced solid malignancies.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1462249-75-7 |
Formula : | C18H11F3N2O |
M.W : | 328.29 |
SMILES Code : | O=C(C1=CC=NC=C1)/C=C/C2=NC3=CC(C(F)(F)F)=CC=C3C=C2 |
MDL No. : | MFCD28386154 |
InChI Key : | IAJOMYABKVAZCN-AATRIKPKSA-N |
Pubchem ID : | 71730058 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
Acute myeloid leukemia cells | 0.9 μM | 96 hours | Evaluate the inhibitory effect of PFK158 combined with meclizine on AML cells, showing synergistic inhibition | PMC7085447 |
DMS53 cells | 0, 2.5, 5, 10 μM | 24 hours | Inhibition of glycolysis, proliferation, spheroid formation, and the expression of cancer stem cell markers CD133, Aldh1, CD44, Sox2, and ABCG2 | PMC9374593 |
H1876 cells | 0, 2.5, 5, 10 μM | 24 hours | Inhibition of glycolysis, proliferation, spheroid formation, and the expression of cancer stem cell markers CD133, Aldh1, CD44, Sox2, and ABCG2 | PMC9374593 |
H1882 cells | 0, 2.5, 5, 10 μM | 24 hours | Inhibition of glycolysis, proliferation, spheroid formation, and the expression of cancer stem cell markers CD133, Aldh1, CD44, Sox2, and ABCG2 | PMC9374593 |
H1048 cells | 0, 2.5, 5, 10 μM | 24 hours | Inhibition of glycolysis, proliferation, spheroid formation, and the expression of cancer stem cell markers CD133, Aldh1, CD44, Sox2, and ABCG2 | PMC9374593 |
Patient-derived ascites cells | 3-5µM | 24 hours | To evaluate the effect of PFK158 on cell viability, results showed that PFK158 treatment reduced cell viability and restored primary cilia formation | PMC8173968 |
OVCAR5 | 10µM | 24 hours | To evaluate the effect of PFK158 on primary cilia formation, results showed that PFK158 treatment significantly restored primary cilia formation | PMC8173968 |
OVCAR8 | 10µM | 24 hours | To evaluate the effect of PFK158 on primary cilia formation, results showed that PFK158 treatment significantly restored primary cilia formation | PMC8173968 |
EMMeso | 0-30μM | 24 and 48 hours | PFK158 treatment inhibited MPM cell viability with IC50 values ranging from 3 to 12μM | PMC6764980 |
NCI-H28 | 0-30μM | 24 and 48 hours | PFK158 treatment inhibited MPM cell viability with IC50 values ranging from 3 to 12μM | PMC6764980 |
OVCAR8 cells | 5 µM | 48 hours | To evaluate the effect of PFK158 on PARPi resistance, results showed that PFK158 inhibited PFKFB3 activity and enhanced PARPi sensitivity. | PMC11762855 |
SKOV3 cells | 5 µM | 48 hours | To evaluate the effect of PFK158 on PARPi resistance, results showed that PFK158 inhibited PFKFB3 activity and enhanced PARPi sensitivity. | PMC11762855 |
ARK-2 | 0-20 μM | 24-72 hours | Inhibited cell proliferation, reduced glucose uptake, ATP production, and lactate dehydrogenase activity | PMC7906909 |
HEC-1B | 0-20 μM | 24-72 hours | Inhibited cell proliferation, reduced glucose uptake, ATP production, and lactate dehydrogenase activity | PMC7906909 |
HeyA8MDR | 5μM | 30 minutes | To evaluate the effect of PFK158 on glucose uptake, results showed that PFK158 treatment significantly decreased glucose uptake | PMC6261695 |
HeyA8 | 5μM | 30 minutes | To evaluate the effect of PFK158 on glucose uptake, results showed that PFK158 treatment significantly decreased glucose uptake | PMC6261695 |
C13 | 5μM | 30 minutes | To evaluate the effect of PFK158 on glucose uptake, results showed that PFK158 treatment significantly decreased glucose uptake | PMC6261695 |
EMMeso | 5 µM | 24 hours | PFK158 treatment inhibited MPM cell viability with IC50 values ranging from 3 to 12μM | PMC9519537 |
NCI-H2052 | 2.5 µM | 24 hours | PFK158 significantly decreased SOX2 and CD133 transcript levels in H2052 cells. | PMC9519537 |
NCI-H28 | 2.5 µM | 24 hours | PFK158 treatment inhibited MPM cell viability with IC50 values ranging from 3 to 12μM | PMC9519537 |
OV2008 | 5μM | 30 minutes | To evaluate the effect of PFK158 on glucose uptake, results showed that PFK158 treatment significantly decreased glucose uptake | PMC6261695 |
THP-1 monocytes | 2.5, 5, or 10 μM | 30 minutes | To evaluate the effect of the PFKFB3 inhibitor 3PO on the chemotaxis of THP-1 monocytes, results showed that 3PO inhibited MCP-1-induced chemotaxis of THP-1 cells. | PMC10420406 |
DMS79 | 2.5 μM | 72 hours | To evaluate the effect of PFK158 on ATP production, glucose uptake, and lactate secretion in MYC-low SCLC cell lines. Results showed that PFK158 had minimal effect on ATP production, glucose uptake, and lactate. | PMC8461854 |
H446 | 2.5 μM | 72 hours | To evaluate the effect of PFK158 on ATP production, glucose uptake, and lactate secretion in MYC-high SCLC cell lines. Results showed that PFK158 significantly attenuated glucose uptake, ATP production, and lactate. | PMC8461854 |
HuH7 cells | 2 or 5 μM | 24 and 48 hrs | PMC7085447 | |
HepG2 cells | 2 or 5 μM | 24 and 48 hrs | Evaluate the effect of SR9009 on BMAL1 mRNA expression | PMC7085447 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
NOG mice | Human hepatocarcinoma cell line xenotransplantation model | Oral | 25 mg/kg | Once daily for two weeks | Evaluate the inhibitory effect of PFK158 combined with meclizine on liver cancer growth, showing significant reduction in tumor burden | PMC7085447 |
SCID-NSG mice | H1048 CSC xenograft model | Intraperitoneally (ip) | 25 mg/kg | Twice a week for 3 weeks | PFK158 treatment and PFKFB3 knockdown significantly reduced tumor growth and weight with reduced expression of cancer stem cell markers, ABCG2, and YAP/TAZ | PMC9374593 |
Nude mice | OVCAR5 xenograft model | Intraperitoneal injection | 50 mg/kg | Once a week for 4 weeks | To evaluate the effect of PFK158 in combination with carboplatin, results showed that PFK158 combined with carboplatin significantly inhibited tumor growth and metastasis | PMC8173968 |
Female athymic nude mice | EMMeso xenograft model | Subcutaneous injection | 30 mg/kg | Twice a week for 2 weeks | PFK158 alone or in combination with carboplatin significantly inhibited tumor growth | PMC6764980 |
BALB/c nude mice | SKOV3 xenograft models | Intraperitoneally | 35 mg/kg | Twice weekly for 28 days | To evaluate the in vivo efficacy of PFK158 combined with PARPi, results showed that the combination significantly inhibited tumor growth and increased DNA damage. | PMC11762855 |
Nude mice | HEC-1B and ARK-2 xenograft models | Intraperitoneal injection | 35 mg/kg | Twice weekly for 14 days | Significantly inhibited tumor growth, reduced tumor volume and weight, and enhanced chemosensitivity | PMC7906909 |
Female athymic nude mice | Highly metastatic PTX-resistant ovarian mouse model | Intraperitoneal injection | 25 mg/kg | PFK158 every 3rd day, CBPt every 3rd day, PTX every 5th day, for 28 days | To evaluate the effect of PFK158 alone or in combination with CBPt/PTX on tumor growth and ascites, results showed that the combination treatment significantly reduced tumor weight and ascites | PMC6261695 |
Female athymic nude mice | MPM xenograft model | 30 mg/kg | Twice a week for 2 weeks | PFK158 significantly reduced tumour burden, tumour weight and tumour volume in TIC-mediated MPM xenografts. | PMC9519537 | |
Mice | Apoe−/− mice | Intraperitoneal injection | 2 mg/kg | 3 times per week for 5 weeks | To evaluate the effect of PFK158 on plaque stability, results showed that PFK158 improved plaque stability. | PMC10420406 |
Nude mice | H446 xenograft model | Intraperitoneal injection | 25 mg/kg | Every 2 days for a total of six treatments | To evaluate the effect of PFK158 on tumor growth in MYC-high SCLC xenograft models. Results showed that PFK158 significantly delayed tumor growth. | PMC8461854 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.05mL 0.61mL 0.30mL |
15.23mL 3.05mL 1.52mL |
30.46mL 6.09mL 3.05mL |
Tags: PFK-158 | PFK158 | PFK 158 | Autophagy | Apoptosis | PFKFB3 | apoptosis | anti-tumor | glycolysis | lactate | anti-proliferative | p-cPLA2 | LC3BII | 1462249-75-7
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL